You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

EVENTS

Leading medical-scientific event on Hemophilia held in Trieste, Italy

Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight

read more 

EVENTS

Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy

A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN

read more 

PLASMA & BIOTHERAPIES

First patient enrolled and treated in Kedrion’s CARES10 clinical study

Phase 3 study to assess efficacy, safety and pharmacokinetics of a 10% IVIg in the treatment of adult PID patients

read more 
  1. EVENTS - 06-11-2014

    Kedrion Participates in International Event on Primary Immunodeficiencies

    Biennial Meeting of the European Society for Immunodeficiencies (ESID) took place in late October in Prague

    read more 
  2. CORPORATE - 17-10-2014

    Kedrion announces more factual, long-term role in Africa

    The company’s efforts try to grant African patients better access to treatments

    read more 
  3. PLASMA & BIOTHERAPIES - 16-10-2014

    Investigating inhibitor development in patients with Hemophilia A

    Lecture on state-of-the-art of the SIPPET Study presented by P.M. Mannucci, sponsored by Grifols, Kedrion and LFB

    read more 
  4. EVENTS - 30-09-2014

    Festival della Salute: conference on self-sufficiency supported by Kedrion

    Plasma and plasma-derived products take centre stage at a workshop with all the stakeholders of the Italian Blood System

    read more 

Pages

For more information please contact: pressoffice@kedrion.com